Results of activity of Chimfarm OJSC (Kazakhstan) for the I half-year of 2003
04.09.03 00:00
/KASE, September 4, 03/ - Chimfarm OJSC (Shymkent), whose shares are
circulating in Kazakhstan stock exchange's (KASE) official "B" listing
category, provided KASE with the financial statement for the I half-year of
2003.
The following indicators are result of the issuer's financial and economic
activity for the I half-year of 2003, based upon the issuer's data (in th. KZT,
unless otherwise specified):
--------------------------------------------------------------
As of As of
Indicator July 1, 02 July 1, 03 Change,%
---------------------------- ---------- ---------- --------
Authorized capital (paid) 1,557,675 1,557,675 0.0
Shareholders' equity 1,645,073 1,872,124 +13.8
Total assets 3,501,400 4,182,255 +19.4
Net working capital 79,236 1,320,207 +1,566.2
Accounts receivable 398,797 456,477 +14.5
Total liabilities 1,856,327 2,310,131 +24.4
Attracted credits 826,329 1,914,210 +131.7
Accounts payable 1,029,998 395,921 -61.6
Sales volume 735,663 995,269 +35.3
Cost of goods sold 461,654 794,111 +72.0
Net income for the period 18,236 15,150 -16.9
Book value of one share, KZT 313.66 356.96 +13.8
--------------------------------------------------------------
Relative to similar period of 2001 there increase of:
- shareholders' equity - by KZT227.1 m. as the result of increase of
additional unpaid capital by 195.6 m., and total sum of undistributed
income by 31.5 m.;
- assets - by KZT680.8 m., including: long-term investments - by 471.2 m.,
expenses of future periods - by 283.0 m., inventory - by 204.3 m. and
other assets - by 101.1 m., whereas there took place decrease of
residual value of fixed assets by 378.8 m.;
- liabilities - by KZT453.8 m., that was caused by increase of attracted
credits volume (long-term) by KZT1.1 bn., whereas there took place
decrease of accounts payable by 634.1 m.;
- sales volume - by KZT259.6 m.;
- cost of goods sold - by KZT332.5 m.
Net income, which Chimfarm OJSC received in the I half-year of 2003,
decreased by KZT3.1 m. in comparison with similar period of 2002.
Company's primary activities - production of drugs; quality
control and conducting of certification tests of drugs, ethyl
alcohol and distillery production by the laboratory, which has
passed accreditation; sale of chemical-pharmaceutical
preparations, medical, sanitary-hygienic means and medical
makings; preparation, purchasing of medical raw stuff;
production and sale of other goods.
[2003-09-04]